Form 4: Soleno Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Kristen Yen, a Senior Vice President at Soleno Therapeutics, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On August 28 and 29, 2024, Kristen Yen, Senior Vice President, Clinical Operations at Soleno Therapeutics Inc. (SLNO), sold shares of the company's common stock.
- The sales were executed in multiple transactions at varying prices.
- The shares were sold to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- Following the reported transactions, Yen still beneficially owns a significant number of Soleno Therapeutics shares, including RSUs.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't inherently indicate positive or negative sentiment regarding the company's prospects.
Industry Context
Sales of shares by company executives are a common occurrence, often related to compensation or personal financial planning. It's important to consider the context of these sales, such as the executive's overall holdings and the company's performance.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price, but are unlikely to significantly affect long-term shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Kristen Yen sold 2,817 shares of Soleno Therapeutics common stock at a weighted average price of $47.1926 and 2,453 shares at a weighted average price of $48.0274. |
| 08/29/2024 | Kristen Yen sold 4,426 shares of Soleno Therapeutics common stock at a weighted average price of $47.1596 and 1,009 shares at a weighted average price of $47.8329. |
| 08/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.